目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION OF DIAGNOSTIC ECG PRODUCTS
2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
2.2.2 MNM REPOSITORY ANALYSIS
2.2.3 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 TOP-DOWN APPROACH
2.2.5 BOTTOM-UP APPROACH
2.2.6 PRIMARY INTERVIEWS
2.2.7 DEMAND-SIDE APPROACH
2.2.8 VOLUME DATA ANALYSIS
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.4.1 STUDY ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 DIAGNOSTIC ECG MARKET OVERVIEW
4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY TYPE AND COUNTRY (2024)
4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY DEVICE TYPE, 2025 VS. 2032
4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION)
4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION)
4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases
5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions
5.2.1.3 Development of wireless monitoring and wearable cardiac devices
5.2.1.4 Growing need for cost-containment across healthcare facilities
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices
5.2.2.2 Technological limitations of diagnostic ECG devices and software
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets to offer high-growth opportunities
5.2.3.2 Expanding access to advanced cardiac diagnostics with AI and CMS support
5.2.4 CHALLENGES
5.2.4.1 Challenges in integrating ECG systems with Electronic Health Records (EHRs)
5.2.4.2 Accuracy challenges in next-generation ECG monitoring
5.3 INDUSTRY TRENDS
5.3.1 MINIATURIZATION AND WEARABLE ECG DEVICES
5.3.2 REMOTE AND HOME-BASED DIAGNOSTICS
5.3.3 HIGH-FIDELITY AND MULTI-LEAD PORTABLE ECGS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Wearable devices and sensors
5.4.1.2 Integration of Artificial Intelligence (AI)
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Wireless ECG devices
5.4.2.2 Mobile apps integration
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Vital sign monitors
5.5 PORTER'S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 BARGAINING POWER OF SUPPLIERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY ANALYSIS
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.3 REGULATORY FRAMEWORK
5.6.3.1 North America
5.6.3.1.1 US
5.6.3.1.2 Canada
5.6.3.2 Europe
5.6.3.3 Asia Pacific
5.6.3.3.1 China
5.6.3.3.2 Japan
5.6.3.3.3 India
5.6.3.4 Latin America
5.6.3.4.1 Brazil
5.6.3.4.2 Mexico
5.6.3.5 Middle East
5.6.3.6 Africa
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR DIAGNOSTIC ECG
5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS
5.8.2 TRADE DATA FOR HS CODE 901811
5.8.2.1 Import data for HS Code 901811
5.8.2.2 Export data for HS Code 901811
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
5.9.1.1 Average selling price of resting ECG, by key player
5.9.1.2 Average selling price for stress ECG, by key player
5.9.1.3 Average selling price of Holter monitors, by key player
5.9.2 AVERAGE SELLING PRICE, BY REGION
5.9.2.1 Average selling price of resting ECG, stress ECG, and Holter monitors, by region
5.10 REIMBURSEMENT SCENARIO
5.11 KEY CONFERENCES & EVENTS, 2025-2026
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 KEY BUYING CRITERIA
5.13 UNMET NEEDS/END-USER EXPECTATIONS
5.14 VALUE CHAIN ANALYSIS
5.15 SUPPLY CHAIN ANALYSIS
5.16 ECOSYSTEM ANALYSIS
5.17 IMPACT OF AI/GEN AI ON DIAGNOSTIC ECG MARKET
5.17.1 INTRODUCTION
5.17.2 MARKET POTENTIAL IN DIAGNOSTIC ECG ECOSYSTEM
5.17.3 AI USE CASES
5.17.4 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES
5.17.5 FUTURE OF GEN AI IN DIAGNOSTIC ECG ECOSYSTEM
5.18 CASE STUDY ANALYSIS
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.20 IMPACT OF 2025 US TARIFF
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.5 IMPACT ON END-USER INDUSTRIES
5.21 INVESTMENT AND FUNDING SCENARIO

6 DIAGNOSTIC ECG MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 RESTING ECG DEVICES
6.2.1.1 Wide availability of resting ECG devices to support market growth
6.2.2 STRESS ECG DEVICES
6.2.2.1 High cost of stress ECG devices to limit adoption
6.2.3 HOLTER MONITORS
6.2.3.1 Growing demand for continuous monitoring to fuel growth
6.2.4 EVENT MONITORS
6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth
6.2.5 IMPLANTABLE LOOP RECORDERS
6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth
6.2.6 MOBILE CARDIAC TELEMETRY DEVICES
6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market
6.2.7 SMART ECG MONITORS
6.2.7.1 Rising adoption of smart/wearable ECG monitors
6.3 SOFTWARE & SERVICES
6.3.1 SHIFT TOWARD AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH

7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE
7.1 INTRODUCTION
7.2 12-LEAD ECG DEVICES
7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH
7.3 5-LEAD ECG DEVICES
7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION
7.4 3-LEAD ECG DEVICES
7.4.1 VITAL TOOL FOR RHYTHM MONITORING TO SUPPORT MARKET GROWTH
7.5 6-LEAD ECG DEVICES
7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH
7.6 SINGLE-LEAD ECG DEVICES
7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES
7.7 OTHER ECG LEAD DEVICES

8 DIAGNOSTIC ECG MARKET, BY TYPE
8.1 INTRODUCTION
8.2 PORTABLE 138 8.2.1 CONVENIENCE AND ACCESSIBILITY OF PORTABLE ECG DEVICES TO ENHANCE EARLY CARDIAC SCREENING
8.3 WEARABLE
8.3.1 RISING DEMAND FOR CONTINUOUS HEART MONITORING IN FITNESS AND CHRONIC DISEASE MANAGEMENT
8.4 IMPLANTABLE 142 8.4.1 HIGH DIAGNOSTIC YIELD FOR ELUSIVE CARDIAC CONDITIONS WITH LONG-TERM MONITORING

9 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY
9.1 INTRODUCTION
9.2 STANDALONE ECG DEVICES
9.2.1 WIDESPREAD ADOPTION OF STANDALONE ECG DEVICES DUE TO OPERATIONAL SIMPLICITY
9.3 PC-BASED ECG DEVICES
9.3.1 GROWING USE FOR ADVANCED ECG DIAGNOSTICS AND INTEGRATION TO SUPPORT REMOTE CARDIAC CARE
9.4 CLOUD-BASED ECG DEVICES
9.4.1 ACCELERATED GROWTH OF CLOUD-BASED ECG SOLUTIONS TO SUPPORT REMOTE CARDIAC CARE

10 DIAGNOSTIC ECG MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS
10.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS TO ACCELERATE MARKET GROWTH
10.3 PRIMARY CARE CENTERS
10.3.1 WIDENING ACCESS TO ECG DIAGNOSTICS IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION
10.4 CARDIAC CENTERS
10.4.1 SPECIALIZED ECG APPLICATIONS IN CARDIAC CENTERS TO DRIVE DEMAND FOR ADVANCED DEVICES
10.5 AMBULATORY SURGICAL CENTERS
10.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN ASCS TO INFLUENCE MARKET DEMAND
10.6 HOME CARE SETTINGS
10.6.1 RISING PREFERENCE FOR REMOTE MONITORING FUELS ECG DEVICE USAGE IN HOME CARE
10.7 URGENT CARE SETTINGS
10.7.1 INTEGRATION OF DIAGNOSTIC ECG IN URGENT CARE SETTINGS FOR TIMELY CARDIAC EVALUATIONS TO FUEL MARKET DEMAND
10.8 OTHER END USERS
10.8.1 DIVERSE ECG APPLICATIONS ACROSS NURSING HOMES, RETAIL CLINICS, SPORTS MEDICINE & RESEARCH TO INFLUENCE MARKET DEMAND

11 DIAGNOSTIC ECG MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 US to command largest share in diagnostic ECG market
11.2.3 CANADA
11.2.3.1 Growing adoption of digital diagnostic ECG systems to drive market growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 High healthcare spending to propel market growth
11.3.3 FRANCE
11.3.3.1 Government support for e-Health to propel market
11.3.4 UK
11.3.4.1 Rising demand for home-based smart ECG devices to support market growth
11.3.5 ITALY
11.3.5.1 Growing focus on improvements in patient care to drive market
11.3.6 SPAIN
11.3.6.1 Rising geriatric population to support market growth in Spain
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
11.4.3 CHINA
11.4.3.1 Government support for infrastructural improvement to drive market growth
11.4.4 INDIA
11.4.4.1 Increasing cardiac disease burden intensifies demand for ECG diagnostics
11.4.5 AUSTRALIA
11.4.5.1 Increased patient volume and favorable government initiatives to drive market
11.4.6 SOUTH KOREA
11.4.6.1 Rising geriatric population to propel market growth
11.4.7 MALAYSIA
11.4.7.1 Increasing CVD burden and national digital health initiatives driving ECG adoption
11.4.8 THAILAND
11.4.8.1 National cardiac screening programs and smart hospital investments driving ECG adoption in Thailand
11.4.9 INDONESIA
11.4.9.1 Rising cardiac disease burden and public health digitalization efforts to drive ECG device uptake in Indonesia
11.4.10 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Improving access to diagnostic services to drive growth
11.5.3 MEXICO
11.5.3.1 Rising heart disease to drive market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Kingdom of Saudi Arabia (KSA)
11.6.2.1.1 Prevalence of CVDs boosting ECG adoption in Saudi Arabia
11.6.2.2 United Arab Emirates (UAE)
11.6.2.2.1 National CVD screening programs and digital health strategies driving market
11.6.2.3 Rest of GCC Countries
11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIAGNOSTIC ECG MARKET
12.3 REVENUE SHARE ANALYSIS (2022-2024)
12.4 MARKET SHARE ANALYSIS, 2024
12.4.1 RANKING OF KEY PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Lead type footprint
12.5.5.5 Type footprint
12.5.5.6 Deployment/Connectivity footprint
12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1 Detailed list of key startups/SME players
12.6.5.2 Competitive benchmarking of key startups/SME players
12.7 BRAND/PRODUCT COMPARISON
12.8 DIAGNOSTIC ECG MARKET: COMPANY VALUATION & FINANCIAL METRICS
12.8.1 FINANCIAL METRICS
12.8.2 COMPANY VALUATION
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 KONINKLIJKE PHILIPS N.V.
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches
13.1.1.3.2 Deals
13.1.1.3.3 Other developments
13.1.1.4 MnM view
13.1.1.4.1 Key strengths/Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 GE HEALTHCARE
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Deals
13.1.2.3.2 Other developments
13.1.2.4 MnM view
13.1.2.4.1 Key strengths/Right to win
13.1.2.4.2 Strategic choice
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 MEDTRONIC
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses and competitive threats
13.1.4 BOSTON SCIENTIFIC CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 MnM view
13.1.4.3.1 Right to win
13.1.4.3.2 Strategic choices
13.1.4.3.3 Weaknesses and competitive threats
13.1.5 ABBOTT LABORATORIES
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Product launches
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 BAXTER (HILL-ROM HOLDINGS, INC.)
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 MnM view
13.1.6.3.1 Key strengths/Right to win
13.1.6.3.2 Strategic choices
13.1.6.3.3 Weaknesses & competitive threats
13.1.7 FUKUDA DENSHI
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 MnM view
13.1.7.3.1 Key strengths
13.1.7.3.2 Strategic choices
13.1.7.3.3 Weaknesses & competitive threats
13.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 MnM view
13.1.8.3.1 Key strengths
13.1.8.3.2 Strategic choices
13.1.8.3.3 Weaknesses & competitive threats
13.1.9 NIHON KOHDEN CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 OSI SYSTEMS, INC.
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Expansions
13.1.11 BITTIUM
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Deals
13.1.12 IRHYTHM TECHNOLOGIES, INC.
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Product launches and approvals
13.1.12.3.2 Deals
13.1.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Product launches and approvals
13.1.13.3.2 Other developments
13.1.14 MIDMARK CORPORATION
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.14.3 Recent developments
13.1.14.3.1 Product launches
13.1.15 BPL MEDICAL TECHNOLOGIES
13.1.15.1 Business overview
13.1.15.2 Products offered
13.1.15.3 Recent developments
13.1.15.3.1 Expansions
13.1.15.3.2 Other developments
13.1.16 SCHILLER
13.1.16.1 Business overview
13.1.16.2 Products offered
13.1.16.3 Recent developments
13.1.16.3.1 Product launches
13.1.16.3.2 Other developments
13.1.17 ACS DIAGNOSTICS
13.1.17.1 Business overview
13.1.17.2 Products offered
13.1.18 ALLENGERS
13.1.18.1 Business overview
13.1.18.2 Products offered
13.1.19 BIONET CO., LTD.
13.1.19.1 Business overview
13.1.19.2 Products offered
13.1.19.3 Recent developments
13.1.19.3.1 Other developments
13.2 OTHER PLAYERS
13.2.1 EDAN INSTRUMENTS, INC.
13.2.2 QINGDAO MEDITECH EQUIPMENT CO., LTD.
13.2.3 CARDIAC INSIGHT, INC.
13.2.4 ALIVECOR, INC.
13.2.5 VITALCONNECT
13.2.6 BTL
13.2.7 BORSAM MEDICAL
13.2.8 NASIFF ASSOCIATES, INC.
13.2.9 VECTRACOR, INC.
13.2.10 BIOMEDICAL INSTRUMENTS CO., LTD.
13.2.11 LIFESIGNALS

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS